Toggle menu

PREFER

Start date:
Historic
End date:
June 2014
Co-ordinated by:
Daiichi Sankyo Deutschland GmbH, Munich

Prefer in VTE Prevention of Thromboembolic Events – European Registry in Venous Thromboembolism

 

Aim

To assess the 12 month direct health care resource use and estimated costs following acute first-time (initial) or recurrent VTE

Trial Design

Multi –national, multi-centre, prospective observational disease registry

Chief Investigator

Dr Petra Laeis, Munich

Local PI

Dr. Matt Reed

Local PI

Dr Matt Reed

Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine

More EMERGE Trials

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Read more

ATTEST2

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Assisting in identifying patients with Humeral shaft fractures in the ED by screening.

Giving patient information sheets to introduce the study, so patient has had adequate time to read and make decision about going into the trial before going to the fracture clinic.

Read more

HU-FIX

The Emergency Medicine Annotated Bioresource Consortium (EM-ABC): A pilot and feasability programme

Read more

EMERGE Biobank

Developing a bioresource for all emergency presentations